Ashleigh E. Moore

481 total citations
8 papers, 359 citations indexed

About

Ashleigh E. Moore is a scholar working on Cancer Research, Molecular Biology and Pharmacology. According to data from OpenAlex, Ashleigh E. Moore has authored 8 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Ashleigh E. Moore's work include Inflammatory mediators and NSAID effects (3 papers), RNA modifications and cancer (2 papers) and MicroRNA in disease regulation (2 papers). Ashleigh E. Moore is often cited by papers focused on Inflammatory mediators and NSAID effects (3 papers), RNA modifications and cancer (2 papers) and MicroRNA in disease regulation (2 papers). Ashleigh E. Moore collaborates with scholars based in United States, Switzerland and Italy. Ashleigh E. Moore's co-authors include Dan A. Dixon, Lisa Young, Lena Sokol, Nicole Meisner‐Kober, Robert J. Schneider, Devon Chenette, Carol S. Lutz, Yuancheng Zhang, José Casabán and Stuart L. James and has published in prestigious journals such as Oncogene, Scientific Reports and British Journal of Pharmacology.

In The Last Decade

Ashleigh E. Moore

8 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashleigh E. Moore United States	7	239	176	41	26	25	8	359
Jipeng Wan China	12	160 0.7×	119 0.7×	9 0.2×	43 1.7×	17 0.7×	25	433
Sanket Joshi Australia	8	191 0.8×	43 0.2×	23 0.6×	44 1.7×	40 1.6×	9	357
Zdeněk Škrott Czechia	10	169 0.7×	57 0.3×	30 0.7×	22 0.8×	103 4.1×	15	360
Yingying Gong China	15	309 1.3×	164 0.9×	9 0.2×	43 1.7×	52 2.1×	32	522
Bing Xie China	10	181 0.8×	49 0.3×	20 0.5×	4 0.2×	21 0.8×	27	326
Joseph C. Nolan United States	10	119 0.5×	47 0.3×	18 0.4×	10 0.4×	29 1.2×	18	335
Huanyao Gao United States	10	207 0.9×	54 0.3×	7 0.2×	17 0.7×	49 2.0×	31	310
Fengying Liu China	11	198 0.8×	65 0.4×	6 0.1×	7 0.3×	21 0.8×	33	390
Kaiyao Shi China	13	128 0.5×	67 0.4×	6 0.1×	64 2.5×	28 1.1×	23	343

Countries citing papers authored by Ashleigh E. Moore

Since Specialization

Citations

This map shows the geographic impact of Ashleigh E. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashleigh E. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashleigh E. Moore more than expected).

Fields of papers citing papers by Ashleigh E. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashleigh E. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashleigh E. Moore. The network helps show where Ashleigh E. Moore may publish in the future.

Co-authorship network of co-authors of Ashleigh E. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Ashleigh E. Moore. A scholar is included among the top collaborators of Ashleigh E. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashleigh E. Moore. Ashleigh E. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Casabán, José, et al.. (2021). Towards MOFs’ mass market adoption: MOF Technologies’ efficient and versatile one-step extrusion of shaped MOFs directly from raw materials. Faraday Discussions. 231(0). 312–325. 33 indexed citations

2.

Moore, Ashleigh E., et al.. (2019). miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer. Scientific Reports. 9(1). 5405–5405. 24 indexed citations

3.

Moore, Ashleigh E., et al.. (2016). Engaging Students in Science through a Nature Hike: A Case of Two Students with ADHD. 13(2). 5 indexed citations

4.

Francesco, Luigia Di, Melania Dovizio, Annalisa Trenti, et al.. (2015). Dysregulated post‐transcriptional control ofCOX‐2 gene expression in gestational diabetic endothelial cells. British Journal of Pharmacology. 172(18). 4575–4587. 9 indexed citations

5.

Moore, Ashleigh E., et al.. (2014). Physiological networks and disease functions of RNA‐binding protein AUF1. Wiley Interdisciplinary Reviews - RNA. 5(4). 549–564. 66 indexed citations

6.

Young, Lisa, Ashleigh E. Moore, Lena Sokol, Nicole Meisner‐Kober, & Dan A. Dixon. (2011). The mRNA Stability Factor HuR Inhibits MicroRNA-16 Targeting of COX-2. Molecular Cancer Research. 10(1). 167–180. 161 indexed citations

7.

Moore, Ashleigh E., Lisa Young, & Dan A. Dixon. (2011). A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation. Oncogene. 31(12). 1592–1598. 44 indexed citations

8.

Moore, Ashleigh E., Lisa Young, & Dan A. Dixon. (2011). MicroRNA and AU-rich element regulation of prostaglandin synthesis. Cancer and Metastasis Reviews. 30(3-4). 419–435. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact